Table 2 Patient characteristics and treatment data (univariable per-patient analyses).

From: Prevalence and impact of ECMO cannula colonization: a single center study

Variable ↓

(all patients included in analyses)

All (n = 58)

Sterile (n = 28)

Colonized (n = 30)

Statistics

Age (years), median (IQR)

58.1 (52.4–62.9)

58.8 (52.6–68.1)

57.6 (51.5–60.2)

p = 0.24M

SOFA score, median (IQR)

10 (9–13)

11 (9–13)

9 (8–14)

p = 0.26M

Multiple organ failure, n (%)

17 (29.3)

8 (28.6)

9 (30.0)

OR 1.07, p > .99F

95% CI 0.32–3.05

Body mass index (kg/m2), median (IQR)

27.7 (24.7–29.6)

27.5 (24.2–28.6)

27.7 (26.0–32.8)

p = 0.09M

Male gender, n (%)

45 (77.6)

21 (75.0)

24 (80.0)

OR 1.33, p = 0.76F

95% CI 0.39–4.47

Diabetes mellitus, n (%)

17 (29.3)

7 (25.0)

10 (33.3)

OR 1.50, p = 0.57F

95% CI 0.46–4.54

Immunosuppression, n (%)

50 (86.2)

22 (78.6)

28 (93.3)

OR 3.82, p = 0.14F

95% CI 0.81–19.6

AB0 blood group 0, n (%)

22 (37.9)

12 (42.9)

10 (33.3)

OR 0.67, p = 0.59F

95% CI 0.23–1.86

COVID-19 ARDS, n (%)

35 (60.3)

13 (46.4)

22 (73.3)

OR 3.17, p = 0.06F

95% CI 1.12–8.67

CPR/cardiogenic shock/pulmonary embolism, n (%)

15 (25.9)

10 (35.7)

5 (16.7)

OR 0.36, p = 0.14F

95% CI 0.11–1.31

Non-COVID-19 ARDS, n (%)

7 (12.1)

4 (14.3)

3 (10.0)

OR 0.67, p = 0.82F

95% CI 0.16–2.71

Septic shock, n (%)

1 (1.7)

1 (3.6)

0 (0)

OR 0.00, p = 0.48F

95% CI 0.00–8.40

V-V, n (%)

38 (65.5)

16 (57.1)

22 (73.3)

OR 2.06, p = 0.27F

95% CI 0.70–5.66F

V-A, n (%)

14 (24.1)

10 (35.7)

4 (13.3)

OR 0.28, p = 0.07F

95% CI 0.09–0.96

V-AV or multiple, n (%)

6 (10.3)

2 (7.1)

4 (13.3)

OR 2.00, p = 0.67F

95% CI 0.43–11.1

RRT or PLEX while on ECMO, n (%)

12 (20.7)

6 (21.4)

6 (20.0)

OR 0.92, p > 0.99F

95% CI 0.27–3.12

Occlusive CHX dressing, n (%)

23 (39.7)

10 (35.7)

13 (43.3)

OR 1.38, p = 0.60F

95% CI 0.50–3.99

Time in hospital until ECMO start (days), median (IQR)

7.0 (1.0–16.3)

6.5 (2–15.5)

9.5 (1–16.3)

p = 0.99M

Duration ECMO run (days), median (IQR)

15.5 (8.0–30.3)

12.0 (4.3–27.8)

20.0 (13.0–37.0)

p = 0.02M

Cannulation scenario

Variable ↓

(patients with all analyzed cannulas inserted on d0 of ECMO run included in analyses)

All (n = 53)

Sterile (n = 26)

Colonized (n = 27)

 

During CPR, n (%)

5 (9.4)

4 (15.4)

1 (3.7)

OR 0.21, p = 0.19F

95% CI 0.02–1.50

During or after CPR, n (%)

7 (13.2)

5 (19.2)

2 (7.4)

OR 0.34, p = 0.25F

95% CI 0.06–1.92

Cannulation problems, n (%)

10 (18.9)

2 (7.7)

8 (29.6)

OR 5.05, p = 0.08F

95% CI 0.96–25.11

Off hours (6 p.m. to 8 a.m.), n (%)

20 (37.7)

9 (34.6)

11 (40.7)

OR 1.29, p = 0.78F

95% CI 0.42–3.90

Out of hospital, n (%)

2 (3.8)

1 (3.8)

1 (3.7)

OR 0.96, p > 0.99F

95% CI 0.05–18.9

Referring hospital, n (%)

28 (52.8)

9 (34.6)

19 (70.4)

OR 4.49, p = 0.01F

95% CI 1.45–14.0

ECMO center, n (%)

23 (43.4)

16 (61.5)

7 (25.9)

OR 0.22, p = 0.01F

95% CI 0.07–0.69

  1. CPR: Cardiopulmonary resuscitation, RRT: Renal replacement therapy, PLEX: Plasma exchange, CHX: Chlorhexidine.
  2. MMann-Whitney U test, FFisher’s exact test.
  3. Significant values (p < 0.05) are in bold.